Era Biotech, S.A.
Records under this name other than the patents Era Biotech, S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 6 of 6 · Back to Era Biotech, S.A.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,637,751 | Recombinant protein body-inducing polypeptides Lapsed on the fee record Ended May 2, 2025 · From the USPTO record | Lapsed on the fee record | Ended May 2, 2025 | From the USPTO record |
| US 9,555,097 | Recombinant protein bodies as immunogen-specific adjuvants Lapsed on the fee record Ended Jan 31, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 31, 2025 | From the USPTO record |
| US 8,163,880 | Production of biologically active proteins Lapsed on the fee record Ended Apr 24, 2024 · From the USPTO record | Lapsed on the fee record | Ended Apr 24, 2024 | From the USPTO record |
| US 8,822,181 | Production of proteins Lapsed on the fee record Ended Sep 2, 2022 · From the USPTO record | Lapsed on the fee record | Ended Sep 2, 2022 | From the USPTO record |
| US 8,802,825 | Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies Lapsed on the fee record Ended Aug 12, 2022 · From the USPTO record | Lapsed on the fee record | Ended Aug 12, 2022 | From the USPTO record |
| US 7,575,898 | Production of peptides and proteins by accumulation in plant endoplasmic reticulum-derived protein bodies Lapsed on the fee record Ended Aug 18, 2021 · From the USPTO record | Lapsed on the fee record | Ended Aug 18, 2021 | From the USPTO record |